Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in Duchenne muscular dystrophy with left ventricular dysfunction
2006-003075-12Phase 4
- Sponsor
- Department Of Paediatric Cardiology
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of carvedilol in Duchenne muscular dystrophy (DMD), sponsored by Department Of Paediatric Cardiology. Primary endpoint: Left ventricular ejection fraction.
02
Drugs
carvedilol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2006-003075-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003075-12.